Larue Catherine 4
4 · Quotient Ltd · Filed Aug 2, 2022
Insider Transaction Report
Form 4
Quotient LtdQTNT
Larue Catherine
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2022-07-31+6,917→ 40,294 total - Exercise/Conversion
Restricted Stock Units
2022-07-31−6,917→ 6,917 total→ Ordinary Shares (6,917 underlying)
Holdings
- 20,790
Ordinary Share Option (Right to Buy)
Exercise: $4.81Exp: 2030-09-01→ Ordinary Shares (20,790 underlying) - 13,611
Ordinary Share Option (Right to Buy)
Exercise: $4.55Exp: 2030-10-31→ Ordinary Shares (13,611 underlying) - 2,171
Ordinary Share Option (Right to Buy)
Exercise: $4.81Exp: 2030-09-01→ Ordinary Shares (2,171 underlying) - 24,040
Ordinary Share Option (Right to Buy)
Exercise: $2.53Exp: 2031-10-31→ Ordinary Shares (24,040 underlying)
Footnotes (6)
- [F1]Restricted Stock Units convert into ordinary shares on a one-for-one basis.
- [F2]6,930 options vested on September 1, 2021 and remain exercisable, and the remaining 13,860 options will vest in two equal installments on September 1, 2022 and September 2, 2023.
- [F3]724 options vested on October 31, 2021 and remain exercisable, and the remaining 723 options will vest on October 31, 2022.
- [F4]All 13,611 options have vested and remain exercisable.
- [F5]On October 31, 2021, the Reporting Person was granted 27,668 restricted stock units, of which 20,751 have vested and have converted into ordinary shares. The remaining 6,917 restricted stock units will vest on October 31, 2022.
- [F6]The options vest and become exercisable on October 31, 2022.